-
How The Liver-Targeted Nano-Drug Delivery System Is Realized
Physiological characteristics of the liver The liver is an important organ involved in the processes of digestion, excretion, detoxification and immunity. Liver diseases are common clinical diseases, such as viral hepatitis, cirrhosis and liver cancer, which are extremely harmful to human health. The liver-targeted drug delivery system is an important way to explore an effective treatment method for liver disease, as it enriches the drug at the site of the liver lesion to exert the curative effect, reducing the amount of drug and the number of drug administration. Liver cells are divided into hepatic parenchymal cells, Kupffer cells and endothelial cells, of which parenchymal cells are the main cells that make up the…
-
What Is The Basic Principle Of Nano-Targeting
After administration of a common pharmaceutical preparation, it is usually freely distributed in the body and then taken up by cells and organs. Due to the existence of various biological barriers in the body, such as the blood-brain barrier and the blood-retinal barrier, only a small part of the drug reaches the target site. The targeted preparation can selectively concentrate the drug on the lesion by means of the nanocarrier, and the lesion can be a target tissue, a target organ, or a target cell or a target in the cell. According to the arrival location of the drug, the targeting can be divided into three levels: the first level refers…
-
How to Achieve Brain Targeting in Nano Drug Delivery System
The blood-brain barrier (BBB) is a barrier system that exists between the blood system and the brain tissue, and is mainly composed of polarized intercellular tight junctions of polarized brain capillary endothelial cells (BCECs). It maintains a relatively stable internal environment for brain tissue, guarantees the normal physiological function of the central nervous system (CNS), and transports nutrients to the brain; but at the same time, its existence also hinders the drug of diagnosis and treatment into the brain. About 98% of small molecule drugs and almost 100% of macromolecular drugs, including proteins, peptides and gene drugs, cannot be directly delivered into the brain by peripheral administration, which is a…